US2020037874A1PendingUtilityA1
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
Est. expiryMay 18, 2027(~0.8 yrs left)· nominal 20-yr term from priority
Inventors:Peter C. SimpsonRobert J. BoockMark C. BristerMonica A. RixmanKum Ming WooLisa NguyenSeth R. BrunnerArthur CheeMelissa A. NicholasMatthew D. WightlinJack PryorDubravka Markovic
A61B 5/14546A61B 5/14735A61B 5/14865A61B 5/14532A61B 5/6848A61B 5/00A61B 5/1486A61B 5/1473A61B 5/7203
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.
Claims
exact text as granted — not AI-modified1 - 26 . (canceled)
27 . A transcutaneous electrochemical glucose sensor configured for implantation in a host, the transcutaneous electrochemical glucose sensor comprising:
a first portion configured to remain outside a body of the host during sensor use; and a second portion configured to be inserted inside the body of the host during sensor use, wherein the second portion comprises:
a working electrode comprising a plurality of sensing regions; and
a reference electrode disposed at least in part on the second portion of the transcutaneous electrochemical glucose sensor.
28 . The transcutaneous electrochemical glucose sensor of claim 27 , wherein the membrane comprises a layer configured to control a diffusion of glucose therethrough.
29 . The transcutaneous electrochemical glucose sensor of claim 27 , wherein the layer comprises polyurethane.
30 . The transcutaneous electrochemical glucose sensor of claim 27 , wherein the transcutaneous electrochemical glucose sensor has a planar shape.
31 . The transcutaneous electrochemical glucose sensor of claim 27 , wherein the reference electrode further comprises silver and silver chloride.
32 . The transcutaneous electrochemical glucose sensor of claim 27 , further comprising a counter electrode disposed at least in part on the second portion of the transcutaneous electrochemical glucose sensor.
33 . The transcutaneous electrochemical sensor of claim 27 , wherein each of the plurality of sensing regions comprises a membrane.
34 . The transcutaneous electrochemical sensor of claim 33 , wherein the membrane comprises an enzyme.
35 . The transcutaneous electrochemical sensor of claim 33 , wherein the membrane is covered at least in part by a diffusion resistance domain.Join the waitlist — get patent alerts
Track US2020037874A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.